_id
691857693c536f8df2317a3c
Ticker
0J4V.LSE
Name
Heron Therapeutics Inc.
Exchange
LSE
Address
100 Regency Forest Drive, Cary, NC, United States, 27518
Country
UK
Sector
Industry
Currency
USD
Website
https://www.herontx.com
Description
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
Last Close
1.2301
Volume
306000
Current Price
1.2405
Change
7.92520732279768
Last Updated
2026-01-08T14:05:41.705Z
Image
https://logo.clearbit.com/www.herontx.com
Ipo Date
-
Market Cap
9882840000
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
38213000
Cost Of Revenue
15384000
Gross Profit
22829000
Operating Expenses
26922000
Operating Income
-4093000
Interest Expense
2900000
Pretax Income
-17495000
Net Income
-17495000
Eps
-0.1027015286354991
Dividends Per Share
-
Shares Outstanding
78019000
Income Tax Expense
-
EBITDA
-13980000
Operating Margin
-10.711014576191348
Total Other Income Expense Net
-13402000
Cash
43068000
Short Term Investments
12419000
Receivables
81047000
Inventories
70025000
Total Current Assets
229400000
Property Plant Equipment
13668000
Total Assets
248950000
Payables
12017000
Short Term Debt
780000
Long Term Debt
-
Total Liabilities
234065000
Equity
14885000
Bs_currency_symbol
-
Depreciation
615000
Change In Working Capital
3640000
Cash From Operations
1331000
Capital Expenditures
0
Cash From Investing
11858000
Cash From Financing
13363000
Net Change In Cash
26552000
Cf_currency_symbol
-
PE
-
PB
14.196620356063152
ROE
-117.53443063486732
ROA
-7.027515565374573
FCF
1331000
Fcf Percent
0.03483107842880695
Piotroski FScore
2
Health Score
11
Deep Value Investing Score
3.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
5.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
6
Net Net Investing Score
4
Quality Investing Score
3
Value Investing Score
2
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
38213000
Quarters > 0 > income Statement > cost Of Revenue
15384000
Quarters > 0 > income Statement > gross Profit
22829000
Quarters > 0 > income Statement > operating Expenses
26922000
Quarters > 0 > income Statement > operating Income
-4093000
Quarters > 0 > income Statement > interest Expense
2900000
Quarters > 0 > income Statement > pretax Income
-17495000
Quarters > 0 > income Statement > net Income
-17495000
Quarters > 0 > income Statement > eps
-0.1027015286354991
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
170348000
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-13980000
Quarters > 0 > income Statement > operating Margin
-10.711014576191348
Quarters > 0 > income Statement > total Other Income Expense Net
-13402000
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
43068000
Quarters > 0 > balance Sheet > short Term Investments
12419000
Quarters > 0 > balance Sheet > receivables
81047000
Quarters > 0 > balance Sheet > inventories
70025000
Quarters > 0 > balance Sheet > total Current Assets
229400000
Quarters > 0 > balance Sheet > property Plant Equipment
13668000
Quarters > 0 > balance Sheet > total Assets
248950000
Quarters > 0 > balance Sheet > payables
12017000
Quarters > 0 > balance Sheet > short Term Debt
780000
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
234065000
Quarters > 0 > balance Sheet > equity
14885000
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-17495000
Quarters > 0 > cash Flow > depreciation
615000
Quarters > 0 > cash Flow > change In Working Capital
3640000
Quarters > 0 > cash Flow > cash From Operations
1331000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
11858000
Quarters > 0 > cash Flow > cash From Financing
13363000
Quarters > 0 > cash Flow > net Change In Cash
26552000
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.1027015286354991
Quarters > 0 > ratios > PB
14.196620356063152
Quarters > 0 > ratios > ROE
-117.53443063486732
Quarters > 0 > ratios > ROA
-7.027515565374573
Quarters > 0 > ratios > FCF
1331000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.03483107842880695
Quarters > 0 > health Score
11
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
37200000
Quarters > 1 > income Statement > cost Of Revenue
9857000
Quarters > 1 > income Statement > gross Profit
27343000
Quarters > 1 > income Statement > operating Expenses
28780000
Quarters > 1 > income Statement > operating Income
-1437000
Quarters > 1 > income Statement > interest Expense
500000
Quarters > 1 > income Statement > pretax Income
-2381000
Quarters > 1 > income Statement > net Income
-2381000
Quarters > 1 > income Statement > eps
-0.01545903129463706
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
154020000
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1270000
Quarters > 1 > income Statement > operating Margin
-3.8629032258064515
Quarters > 1 > income Statement > total Other Income Expense Net
-944000
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
16515999
Quarters > 1 > balance Sheet > short Term Investments
24117000
Quarters > 1 > balance Sheet > receivables
79931000
Quarters > 1 > balance Sheet > inventories
72965000
Quarters > 1 > balance Sheet > total Current Assets
210923000
Quarters > 1 > balance Sheet > property Plant Equipment
15084000
Quarters > 1 > balance Sheet > total Assets
232090000
Quarters > 1 > balance Sheet > payables
12037000
Quarters > 1 > balance Sheet > short Term Debt
176743000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
259348000
Quarters > 1 > balance Sheet > equity
-27258000
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-2381000
Quarters > 1 > cash Flow > depreciation
611000
Quarters > 1 > cash Flow > change In Working Capital
-11991000
Quarters > 1 > cash Flow > cash From Operations
-10868000
Quarters > 1 > cash Flow > capital Expenditures
208000
Quarters > 1 > cash Flow > cash From Investing
7334000
Quarters > 1 > cash Flow > cash From Financing
781000
Quarters > 1 > cash Flow > net Change In Cash
-2753000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.01545903129463706
Quarters > 1 > ratios > PB
-7.0093847677745975
Quarters > 1 > ratios > ROE
8.73505026047399
Quarters > 1 > ratios > ROA
-1.0258951268904304
Quarters > 1 > ratios > FCF
-11076000
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-0.29774193548387096
Quarters > 1 > health Score
21
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
38903000
Quarters > 2 > income Statement > cost Of Revenue
10736000
Quarters > 2 > income Statement > gross Profit
28167000
Quarters > 2 > income Statement > operating Expenses
25013000
Quarters > 2 > income Statement > operating Income
3154000
Quarters > 2 > income Statement > interest Expense
500000
Quarters > 2 > income Statement > pretax Income
2635000
Quarters > 2 > income Statement > net Income
2635000
Quarters > 2 > income Statement > eps
0.013381000502739677
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
196921000
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
3705000
Quarters > 2 > income Statement > operating Margin
8.107343906639592
Quarters > 2 > income Statement > total Other Income Expense Net
-519000
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
19269000
Quarters > 2 > balance Sheet > short Term Investments
31410000
Quarters > 2 > balance Sheet > receivables
78736000
Quarters > 2 > balance Sheet > inventories
56932000
Quarters > 2 > balance Sheet > total Current Assets
212841000
Quarters > 2 > balance Sheet > property Plant Equipment
16628000
Quarters > 2 > balance Sheet > total Assets
235752000
Quarters > 2 > balance Sheet > payables
12333000
Quarters > 2 > balance Sheet > short Term Debt
2290000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
264205000
Quarters > 2 > balance Sheet > equity
-28453000
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
2635000
Quarters > 2 > cash Flow > depreciation
762000
Quarters > 2 > cash Flow > change In Working Capital
-15087000
Quarters > 2 > cash Flow > cash From Operations
-8870000
Quarters > 2 > cash Flow > capital Expenditures
109000
Quarters > 2 > cash Flow > cash From Investing
2273000
Quarters > 2 > cash Flow > cash From Financing
64000
Quarters > 2 > cash Flow > net Change In Cash
-6533000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
0.013381000502739677
Quarters > 2 > ratios > PB
-8.58540401715109
Quarters > 2 > ratios > ROE
-9.260886374020314
Quarters > 2 > ratios > ROA
1.117699955885846
Quarters > 2 > ratios > FCF
-8979000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.23080482225021207
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
40781000
Quarters > 3 > income Statement > cost Of Revenue
10228000
Quarters > 3 > income Statement > gross Profit
30553000
Quarters > 3 > income Statement > operating Expenses
26380000
Quarters > 3 > income Statement > operating Income
4173000
Quarters > 3 > income Statement > interest Expense
4432000
Quarters > 3 > income Statement > pretax Income
3663000
Quarters > 3 > income Statement > net Income
3663000
Quarters > 3 > income Statement > eps
0.02391757154703528
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
153151000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
5126000
Quarters > 3 > income Statement > operating Margin
10.2327064073956
Quarters > 3 > income Statement > total Other Income Expense Net
-510000
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
25802000
Quarters > 3 > balance Sheet > short Term Investments
33481000
Quarters > 3 > balance Sheet > receivables
78881000
Quarters > 3 > balance Sheet > inventories
53160000
Quarters > 3 > balance Sheet > total Current Assets
209014000
Quarters > 3 > balance Sheet > property Plant Equipment
17650000
Quarters > 3 > balance Sheet > total Assets
233147000
Quarters > 3 > balance Sheet > payables
11709000
Quarters > 3 > balance Sheet > short Term Debt
3037000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
266798000
Quarters > 3 > balance Sheet > equity
-33651000
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
3663000
Quarters > 3 > cash Flow > depreciation
581000
Quarters > 3 > cash Flow > change In Working Capital
-18343000
Quarters > 3 > cash Flow > cash From Operations
-11780000
Quarters > 3 > cash Flow > capital Expenditures
638000
Quarters > 3 > cash Flow > cash From Investing
11418000
Quarters > 3 > cash Flow > cash From Financing
423000
Quarters > 3 > cash Flow > net Change In Cash
61000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
0.02391757154703528
Quarters > 3 > ratios > PB
-5.645710840688241
Quarters > 3 > ratios > ROE
-10.885263439422307
Quarters > 3 > ratios > ROA
1.5711117878420051
Quarters > 3 > ratios > FCF
-12418000
Quarters > 3 > ratios > Piotroski FScore
1
Quarters > 3 > ratios > fcf Percent
-0.3045045486868885
Quarters > 3 > health Score
31
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
144285000
Annuals > 0 > income Statement > cost Of Revenue
38648000
Annuals > 0 > income Statement > gross Profit
105637000
Annuals > 0 > income Statement > operating Expenses
117165000
Annuals > 0 > income Statement > operating Income
-11528000
Annuals > 0 > income Statement > interest Expense
6032000
Annuals > 0 > income Statement > pretax Income
-13580000
Annuals > 0 > income Statement > net Income
-13580000
Annuals > 0 > income Statement > eps
-0.08907897067215921
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
152449000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-5056000
Annuals > 0 > income Statement > operating Margin
-7.9897425234778385
Annuals > 0 > income Statement > total Other Income Expense Net
-2052000
Annuals > 0 > income Statement > currency_symbol
-
Annuals > 0 > balance Sheet > cash
25802000
Annuals > 0 > balance Sheet > short Term Investments
33481000
Annuals > 0 > balance Sheet > receivables
78881000
Annuals > 0 > balance Sheet > inventories
53160000
Annuals > 0 > balance Sheet > total Current Assets
209014000
Annuals > 0 > balance Sheet > property Plant Equipment
17650000
Annuals > 0 > balance Sheet > total Assets
233147000
Annuals > 0 > balance Sheet > payables
11709000
Annuals > 0 > balance Sheet > short Term Debt
6074000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
266798000
Annuals > 0 > balance Sheet > equity
-33651000
Annuals > 0 > balance Sheet > currency_symbol
-
Annuals > 0 > cash Flow > net Income
-13580000
Annuals > 0 > cash Flow > depreciation
2492000
Annuals > 0 > cash Flow > change In Working Capital
-27603000
Annuals > 0 > cash Flow > cash From Operations
-22529000
Annuals > 0 > cash Flow > capital Expenditures
1706000
Annuals > 0 > cash Flow > cash From Investing
18714000
Annuals > 0 > cash Flow > cash From Financing
940000
Annuals > 0 > cash Flow > net Change In Cash
-2875000
Annuals > 0 > cash Flow > currency_symbol
-
Annuals > 0 > ratios > PE
-0.08907897067215921
Annuals > 0 > ratios > PB
-5.619832530979763
Annuals > 0 > ratios > ROE
40.355412914920805
Annuals > 0 > ratios > ROA
-5.82465140018958
Annuals > 0 > ratios > FCF
-24235000
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-0.16796617805038638
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
127044000
Annuals > 1 > income Statement > cost Of Revenue
117002000
Annuals > 1 > income Statement > gross Profit
10042000
Annuals > 1 > income Statement > operating Expenses
120657000
Annuals > 1 > income Statement > operating Income
-110615000
Annuals > 1 > income Statement > interest Expense
3868000
Annuals > 1 > income Statement > pretax Income
-110559000
Annuals > 1 > income Statement > net Income
-110559000
Annuals > 1 > income Statement > eps
-0.8003692040395266
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
138135000
Annuals > 1 > income Statement > income Tax Expense
17600000
Annuals > 1 > income Statement > EBITDA
-103792000
Annuals > 1 > income Statement > operating Margin
-87.068259815497
Annuals > 1 > income Statement > total Other Income Expense Net
56000
Annuals > 1 > income Statement > currency_symbol
-
Annuals > 1 > balance Sheet > cash
28677000
Annuals > 1 > balance Sheet > short Term Investments
51732000
Annuals > 1 > balance Sheet > receivables
60137000
Annuals > 1 > balance Sheet > inventories
42110000
Annuals > 1 > balance Sheet > total Current Assets
188774000
Annuals > 1 > balance Sheet > property Plant Equipment
25604000
Annuals > 1 > balance Sheet > total Assets
222506000
Annuals > 1 > balance Sheet > payables
3240000
Annuals > 1 > balance Sheet > short Term Debt
3075000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
256479000
Annuals > 1 > balance Sheet > equity
-33973000
Annuals > 1 > balance Sheet > currency_symbol
-
Annuals > 1 > cash Flow > net Income
-110559000
Annuals > 1 > cash Flow > depreciation
2899000
Annuals > 1 > cash Flow > change In Working Capital
16775000
Annuals > 1 > cash Flow > cash From Operations
-58789000
Annuals > 1 > cash Flow > capital Expenditures
1545000
Annuals > 1 > cash Flow > cash From Investing
17995000
Annuals > 1 > cash Flow > cash From Financing
54107000
Annuals > 1 > cash Flow > net Change In Cash
13313000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.8003692040395266
Annuals > 1 > ratios > PB
-5.043901554175375
Annuals > 1 > ratios > ROE
325.4319606746534
Annuals > 1 > ratios > ROA
-49.68809829847285
Annuals > 1 > ratios > FCF
-60334000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-0.47490633166462015
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
107672000
Annuals > 2 > income Statement > cost Of Revenue
54874000
Annuals > 2 > income Statement > gross Profit
52798000
Annuals > 2 > income Statement > operating Expenses
222056000
Annuals > 2 > income Statement > operating Income
-169258000
Annuals > 2 > income Statement > interest Expense
2474000
Annuals > 2 > income Statement > pretax Income
-182024000
Annuals > 2 > income Statement > net Income
-182024000
Annuals > 2 > income Statement > eps
-1.6718468716705244
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
108876000
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-176661000
Annuals > 2 > income Statement > operating Margin
-157.19778586819228
Annuals > 2 > income Statement > total Other Income Expense Net
-12766000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
15364000
Annuals > 2 > balance Sheet > short Term Investments
69488000
Annuals > 2 > balance Sheet > receivables
52049000
Annuals > 2 > balance Sheet > inventories
54573000
Annuals > 2 > balance Sheet > total Current Assets
205435000
Annuals > 2 > balance Sheet > property Plant Equipment
29805000
Annuals > 2 > balance Sheet > total Assets
250951000
Annuals > 2 > balance Sheet > payables
3225000
Annuals > 2 > balance Sheet > short Term Debt
2694000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
237379000
Annuals > 2 > balance Sheet > equity
13572000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-182024000
Annuals > 2 > cash Flow > depreciation
3091000
Annuals > 2 > cash Flow > change In Working Capital
-10506000
Annuals > 2 > cash Flow > cash From Operations
-146912000
Annuals > 2 > cash Flow > capital Expenditures
1825000
Annuals > 2 > cash Flow > cash From Investing
-3324000
Annuals > 2 > cash Flow > cash From Financing
75059000
Annuals > 2 > cash Flow > net Change In Cash
-75177000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-1.6718468716705244
Annuals > 2 > ratios > PB
9.951420424403182
Annuals > 2 > ratios > ROE
-1341.1730032419687
Annuals > 2 > ratios > ROA
-72.53368187415073
Annuals > 2 > ratios > FCF
-148737000
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-1.3813897763578276
Annuals > 2 > health Score
8
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
86346000
Annuals > 3 > income Statement > cost Of Revenue
46021000
Annuals > 3 > income Statement > gross Profit
40325000
Annuals > 3 > income Statement > operating Expenses
256553000
Annuals > 3 > income Statement > operating Income
-216228000
Annuals > 3 > income Statement > interest Expense
2410000
Annuals > 3 > income Statement > pretax Income
-220683000
Annuals > 3 > income Statement > net Income
-220683000
Annuals > 3 > income Statement > eps
-2.2410963633963297
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
98471000
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-215252000
Annuals > 3 > income Statement > operating Margin
-250.42040163991382
Annuals > 3 > income Statement > total Other Income Expense Net
-4455000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
90541000
Annuals > 3 > balance Sheet > short Term Investments
67039000
Annuals > 3 > balance Sheet > receivables
35499000
Annuals > 3 > balance Sheet > inventories
48382000
Annuals > 3 > balance Sheet > total Current Assets
254423000
Annuals > 3 > balance Sheet > property Plant Equipment
33563000
Annuals > 3 > balance Sheet > total Assets
305706000
Annuals > 3 > balance Sheet > payables
3803000
Annuals > 3 > balance Sheet > short Term Debt
4834000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
228136000
Annuals > 3 > balance Sheet > equity
77570000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-220683000
Annuals > 3 > cash Flow > depreciation
3925000
Annuals > 3 > cash Flow > change In Working Capital
-35079000
Annuals > 3 > cash Flow > cash From Operations
-203354000
Annuals > 3 > cash Flow > capital Expenditures
3022000
Annuals > 3 > cash Flow > cash From Investing
32729000
Annuals > 3 > cash Flow > cash From Financing
156028000
Annuals > 3 > cash Flow > net Change In Cash
-14597000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-2.2410963633963297
Annuals > 3 > ratios > PB
1.5747489428902925
Annuals > 3 > ratios > ROE
-284.49529457264407
Annuals > 3 > ratios > ROA
-72.18798453416028
Annuals > 3 > ratios > FCF
-206376000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-2.3901049266902925
Annuals > 3 > health Score
20
Valuation > metrics > PE
-0.1027015286354991
Valuation > metrics > PB
14.196620356063152
Valuation > final Score
20
Valuation > verdict
373.2% Overvalued
Profitability > metrics > ROE
-117.53443063486732
Profitability > metrics > ROA
-7.626416739319965
Profitability > metrics > Net Margin
-0.4578284876874362
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
15.724890829694322
Risk > metrics > Interest Coverage
-1.4113793103448276
Risk > final Score
0
Risk > verdict
High
Liquidity > metrics > Current Ratio
17.926076424161913
Liquidity > metrics > Quick Ratio
12.454090802531843
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
70
Prev Valuations > 2
70
Prev Profitabilities > 0
17
Prev Profitabilities > 1
14
Prev Profitabilities > 2
19
Prev Risks > 0
19
Prev Risks > 1
55
Prev Risks > 2
34
Prev Liquidities > 0
64
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:54:25.576Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-02-24
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-
Earnings History > 0 > eps Estimate
-0.03
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-04
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
BeforeMarket
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.1027
Earnings History > 1 > eps Estimate
-0.01
Earnings History > 1 > eps Difference
-0.0927
Earnings History > 1 > surprise Percent
-927
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-11
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
AfterMarket
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0155
Earnings History > 2 > eps Estimate
-0.01
Earnings History > 2 > eps Difference
-0.0055
Earnings History > 2 > surprise Percent
-55
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-05-05
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.0134
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2025-03-10
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
0.0239
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-11-12
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
AfterMarket
Earnings History > 5 > currency
-
Earnings History > 5 > eps Actual
-0.0317
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-06
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
-
Earnings History > 6 > eps Actual
-0.0606
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-05-07
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
-
Earnings History > 7 > eps Actual
-0.0209
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-12
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
-
Earnings History > 8 > eps Actual
-0.0714
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-14
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
-
Earnings History > 9 > eps Actual
-0.1725
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-14
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
-
Earnings History > 10 > eps Actual
-0.3513
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-05-11
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
AfterMarket
Earnings History > 11 > currency
-
Earnings History > 11 > eps Actual
-0.2748
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-23
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
-
Earnings History > 12 > eps Actual
-0.1667
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-11-08
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
-
Earnings History > 13 > eps Actual
-0.3751
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-09
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
AfterMarket
Earnings History > 14 > currency
-
Earnings History > 14 > eps Actual
-0.5504
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-09
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
-
Earnings History > 15 > eps Actual
-0.6256
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-02-28
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
AfterMarket
Earnings History > 16 > currency
-
Earnings History > 16 > eps Actual
-0.5359
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-11-03
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
-
Earnings History > 17 > eps Actual
-0.5143
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2021-06-30
Earnings History > 18 > report Date
2021-08-09
Earnings History > 18 > date
2021-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
-
Earnings History > 18 > eps Actual
-0.6197
Earnings History > 18 > eps Estimate
-
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2021-03-31
Earnings History > 19 > report Date
2021-05-10
Earnings History > 19 > date
2021-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
-
Earnings History > 19 > eps Actual
-0.5757
Earnings History > 19 > eps Estimate
-
Earnings History > 19 > eps Difference
0
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-12-31
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
-
Earnings History > 20 > eps Actual
-0.6838
Earnings History > 20 > eps Estimate
-
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-09-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-09-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
-
Earnings History > 21 > eps Actual
-0.6409
Earnings History > 21 > eps Estimate
-
Earnings History > 21 > eps Difference
0
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-06-30
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-06-30
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
-
Earnings History > 22 > eps Actual
-0.6081
Earnings History > 22 > eps Estimate
-
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2020-03-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2020-03-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
-
Earnings History > 23 > eps Actual
-0.5705
Earnings History > 23 > eps Estimate
-
Earnings History > 23 > eps Difference
0
Earnings History > 23 > surprise Percent
-
Earnings History > 24 > period
2019-12-31
Earnings History > 24 > report Date
2019-12-31
Earnings History > 24 > date
2019-12-31
Earnings History > 24 > before After Market
-
Earnings History > 24 > currency
-
Earnings History > 24 > eps Actual
-0.65
Earnings History > 24 > eps Estimate
-
Earnings History > 24 > eps Difference
0
Earnings History > 24 > surprise Percent
-
Earnings History > 25 > period
2019-09-30
Earnings History > 25 > report Date
2019-09-30
Earnings History > 25 > date
2019-09-30
Earnings History > 25 > before After Market
-
Earnings History > 25 > currency
-
Earnings History > 25 > eps Actual
-0.4203
Earnings History > 25 > eps Estimate
-
Earnings History > 25 > eps Difference
0
Earnings History > 25 > surprise Percent
-
Earnings History > 26 > period
2019-06-30
Earnings History > 26 > report Date
2019-06-30
Earnings History > 26 > date
2019-06-30
Earnings History > 26 > before After Market
-
Earnings History > 26 > currency
-
Earnings History > 26 > eps Actual
-0.6313
Earnings History > 26 > eps Estimate
-
Earnings History > 26 > eps Difference
0
Earnings History > 26 > surprise Percent
-
Earnings History > 27 > period
2019-03-31
Earnings History > 27 > report Date
2019-03-31
Earnings History > 27 > date
2019-03-31
Earnings History > 27 > before After Market
-
Earnings History > 27 > currency
-
Earnings History > 27 > eps Actual
-0.8035
Earnings History > 27 > eps Estimate
-
Earnings History > 27 > eps Difference
0
Earnings History > 27 > surprise Percent
-
Earnings History > 28 > period
2018-12-31
Earnings History > 28 > report Date
2018-12-31
Earnings History > 28 > date
2018-12-31
Earnings History > 28 > before After Market
-
Earnings History > 28 > currency
-
Earnings History > 28 > eps Actual
-0.6347
Earnings History > 28 > eps Estimate
-
Earnings History > 28 > eps Difference
0
Earnings History > 28 > surprise Percent
-
Earnings History > 29 > period
2018-09-30
Earnings History > 29 > report Date
2018-09-30
Earnings History > 29 > date
2018-09-30
Earnings History > 29 > before After Market
-
Earnings History > 29 > currency
-
Earnings History > 29 > eps Actual
-0.4928
Earnings History > 29 > eps Estimate
-
Earnings History > 29 > eps Difference
0
Earnings History > 29 > surprise Percent
-
Earnings History > 30 > period
2018-06-30
Earnings History > 30 > report Date
2018-06-30
Earnings History > 30 > date
2018-06-30
Earnings History > 30 > before After Market
-
Earnings History > 30 > currency
-
Earnings History > 30 > eps Actual
-0.5374
Earnings History > 30 > eps Estimate
-
Earnings History > 30 > eps Difference
0
Earnings History > 30 > surprise Percent
-
Earnings History > 31 > period
2018-03-31
Earnings History > 31 > report Date
2018-03-31
Earnings History > 31 > date
2018-03-31
Earnings History > 31 > before After Market
-
Earnings History > 31 > currency
-
Earnings History > 31 > eps Actual
-0.8075
Earnings History > 31 > eps Estimate
-
Earnings History > 31 > eps Difference
0
Earnings History > 31 > surprise Percent
-
Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron), an extended-release injection for the prevention of acute and delayed nausea and vomiting associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens; and CINVANTI, an intravenous formulation of aprepitant, a substance P/neurokinin-1 receptor antagonist for the prevention of acute and delayed nausea and vomiting associated with highly emetogenic cancer chemotherapy, as well as nausea and vomiting associated with moderately emetogenic cancer chemotherapy. The company is also developing ZYNRELEF, a dual-acting local anesthetic that delivers a fixed-dose combination of the local anesthetic bupivacaine and a low dose of the nonsteroidal anti-inflammatory drug meloxicam; and APONVIE, an intravenous formulation of a substance P/neurokinin-1 receptor antagonist indicated for the prevention of postoperative nausea and vomiting in adults. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in Cary, North Carolina.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Heron Therapeutics Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.03
Date
2025-09-30
EPS Actual
-0.1027
EPS Estimate
-0.01
EPS Difference
-0.0927
Surprise Percent
-927%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.